Neurent Medical Announces Landmark Positive Results for NEUROMARK® System in Chronic Rhinitis Treatment Neurent Medical has published exciting results from its clinical trial for the NEUROMARK® System, showcasing significant improvements in chronic rhinitis treatment, enhancing patients' quality of life.

Neurent Medical Announces Landmark Positive Results for NEUROMARK® System in Chronic Rhinitis Treatment #Ireland #Galway #Neurent_Medical #NEUROMARK #Chronic_Rhinitis

Neurent Medical Secures €62.5 Million to Expand NEUROMARK® in Treating Chronic Rhinitis Neurent Medical has successfully raised €62.5 million to enhance the commercial reach of its NEUROMARK® treatment for chronic rhinitis, significantly impacting patient care.

Neurent Medical Secures €62.5 Million to Expand NEUROMARK® in Treating Chronic Rhinitis #Ireland #Galway #Neurent_Medical #NEUROMARK #Chronic_Rhinitis

NEUROMARK® Expands Access Through UnitedHealthcare's Medicare Advantage Policy Changes Neurent Medical announces expanded access to NEUROMARK® under UnitedHealthcare's Medicare Advantage policy, enhancing treatment for chronic rhinitis.

NEUROMARK® Expands Access Through UnitedHealthcare's Medicare Advantage Policy Changes #United_States #Braintree #Neurent_Medical #NEUROMARK #Chronic_Rhinitis

Neurent Medical's NEUROMARK® Treatment Shows Lasting Effects in Chronic Rhinitis Patients for Two Years Neurent Medical's NEUROMARK® treatment provides significant two-year benefits for chronic rhinitis patients, confirming its efficacy and durability.

Neurent Medical's NEUROMARK® Treatment Shows Lasting Effects in Chronic Rhinitis Patients for Two Years #Ireland #Galway #Neurent_Medical #NEUROMARK #Chronic_Rhinitis

Neurent Medical's NEUROMARK Treatment Now Covered by Cigna, Enhancing Access for Patients Neurent Medical announces enhanced accessibility for patients with chronic rhinitis as Cigna updates its coverage policy for NEUROMARK treatment, reflecting growing acceptance.

Neurent Medical's NEUROMARK Treatment Now Covered by Cigna, Enhancing Access for Patients #Ireland #Galway #Cigna_Healthcare #Neurent_Medical #NEUROMARK

Neurent Medical Earns FDA 510(k) Clearance for NEUROMARK® System to Transform Chronic Rhinitis Treatment Neurent Medical has received FDA 510(k) clearance for its advanced NEUROMARK® System aimed at improving treatment for chronic rhinitis, enhancing patient care.

Neurent Medical Earns FDA 510(k) Clearance for NEUROMARK® System to Transform Chronic Rhinitis Treatment #Ireland #Galway #Neurent_Medical #NEUROMARK #Chronic_Rhinitis